Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
28
NMPA:28
Drug Approvals
Telmisartan and Amlodipine Tablets
- Product Name
- 替米沙坦氨氯地平片
- Approval Number
- 国药准字H20253320
- Approval Date
- Jan 24, 2025
NMPA
Olmesartan Medoxomil and Amlodipine Besylate Tablets
- Product Name
- 奥美沙坦酯氨氯地平片
- Approval Number
- 国药准字H20253169
- Approval Date
- Jan 14, 2025
NMPA
Compound Glycyrrhizin Tablets
- Product Name
- 复方甘草酸苷片
- Approval Number
- 国药准字H20244609
- Approval Date
- Aug 5, 2024
NMPA
Procaterol Hydrochloride Granules
- Product Name
- 盐酸丙卡特罗颗粒
- Approval Number
- 国药准字H20243643
- Approval Date
- Apr 30, 2024
NMPA
Metformin Hydrochloride and Empagliflozin Tablets（Ⅰ）
- Product Name
- 二甲双胍恩格列净片(Ⅰ)
- Approval Number
- 国药准字H20243533
- Approval Date
- Apr 17, 2024
NMPA
Atomoxetine Hydrochloride Capsules
- Product Name
- 盐酸托莫西汀胶囊
- Approval Number
- 国药准字H20233713
- Approval Date
- Jun 14, 2023
NMPA
Atomoxetine Hydrochloride Capsules
- Product Name
- 盐酸托莫西汀胶囊
- Approval Number
- 国药准字H20233712
- Approval Date
- Jun 14, 2023
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found